A randomised, placebo-controlled trial of Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia in chronic kidney disease (2011-2015)
Experts
Professor
David Johnson
NHMRC Leadership Fellow
Centre for Health Services Research
Faculty of Health, Medicine and Behavioural Sciences